Can three-times-a-aay cyclosporine neoral avoid cylosporine toxicity in renal transplant recipients? a pharmacokinetic study

By Swart N.   Botha J.   Tandon V.   Michaels P.   Pontin A.R.   Halkett J.   Pascoe M.D.   Kahn D.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3140-3141

Elsevier

Access to resources Recommend Favorite

Protocol biopsies in renal transplant patients: three-years' follow-up

By Veronese F.V.   Noronha I.L.   Manfro R.C.   Edelweiss M.I.   Goldberg J.   Oliveira S.G.   Oliveira I.B.   Leitao T.G.   Goncalves L.F.  

Transplantation Proceedings, Vol. 34, Iss. 2, 2002-03 ,pp. : 500-501

Elsevier

Access to resources Recommend Favorite

Experience With New Cyclosporine Formulations: Consupren and Neoral in Renal Transplant Patients

By Barbari A.   Stephan A.   Kamel G.   Kilany H.   Masri M.A.  

Transplantation Proceedings, Vol. 29, Iss. 7, 1997-11 ,pp. : 2941-2944

Elsevier

Access to resources Recommend Favorite

Cyclosporine neoral profiling in japanese renal transplant recipients

By Aikawa A.   Arai K.   Tajima E.   Kawamura T.   Ogiwara H.   Sakai K.   Mizuiri S.   Ohara T.   Hasegawa A.   Kosugi T.   Kusano A.   Matsuo K.   Obayashi M.   Kurokawa M.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3142-3145

Elsevier

Access to resources Recommend Favorite

Neoral-to-gengraf conversion in renal transplant recipients

By Carnahan W.   Cooper T.Y.  

Transplantation Proceedings, Vol. 35, Iss. 4, 2003-06 ,pp. : 1308-1313

Elsevier

Access to resources Recommend Favorite